Cancer Imaging is the official journal of the International Cancer Imaging Society (ICIS)
Articles
Page 15 of 21
-
Citation: Cancer Imaging 2015 15(Suppl 1):P52
-
Whole-body diffusion-weighted MRI for staging of women with cancer during pregnancy: a pilot study
Citation: Cancer Imaging 2015 15(Suppl 1):P50 -
MR and PET/CT imaging in diagnosis of large pelvic masses
Citation: Cancer Imaging 2015 15(Suppl 1):P48 -
Do we need to wait? Does reducing time to prostate MRI postbiopsy interfere with staging?
Citation: Cancer Imaging 2015 15(Suppl 1):P46 -
MRI rectal cancer in Australia and New Zealand: an audit from the PETACC-6 trial
Citation: Cancer Imaging 2015 15(Suppl 1):P44 -
FDG-PET/CT pitfalls in gynecological and genitourinary oncological imaging
Citation: Cancer Imaging 2015 15(Suppl 1):P42 -
Brain lesions in oncology patients: recognising metastatic versus non metastatic lesions
Citation: Cancer Imaging 2015 15(Suppl 1):O40 -
Tumour characterisation, staging and operability assessment in ovarian carcinoma: whole body diffusion-weighted MRI versus CT
Citation: Cancer Imaging 2015 15(Suppl 1):P40 -
Patient selection and treatment response assessment in radium-223 therapy
Citation: Cancer Imaging 2015 15(Suppl 1):P38 -
Pediatric bone and soft-tissue sarcomas
Citation: Cancer Imaging 2015 15(Suppl 1):O36 -
MRI in intracavitary brachytherapy planning for cervical cancer malignancy, the pitfalls and complications
Citation: Cancer Imaging 2015 15(Suppl 1):P36 -
Imaging techniques to diagnose radiation damage
Citation: Cancer Imaging 2015 15(Suppl 1):O34 -
Detection of gynaecological cancer in pregnancy
Citation: Cancer Imaging 2015 15(Suppl 1):P34 -
Tractography of the prostatic neurovascular bundles: technique and interpretation
Citation: Cancer Imaging 2015 15(Suppl 1):P33 -
Reporting oncoimaging in the appropriate oncology setting
Citation: Cancer Imaging 2015 15(Suppl 1):P32 -
RECIST criteria: our experience in daily practice
Citation: Cancer Imaging 2015 15(Suppl 1):P31 -
Percutaneous treatment of liver metastases
Citation: Cancer Imaging 2015 15(Suppl 1):O30 -
Structured reporting of metastatic disease for improving communication in comprehensive cancer centers- a feasibility study
Citation: Cancer Imaging 2015 15(Suppl 1):P30 -
Reducing error: benign abnormalities mimicking malignancy when reporting scans of patients with known malignancy
Citation: Cancer Imaging 2015 15(Suppl 1):P29 -
Are contouring time and multimodality imaging prognostic factors for radiation therapy of advanced head and neck cancer?
Citation: Cancer Imaging 2015 15(Suppl 1):P28 -
Factors on patency periods of subcutaneous central venous port: long-term results of 1,408 patients
Citation: Cancer Imaging 2015 15(Suppl 1):P27 -
Thoracic pseudotumours: a pictorial essay
Citation: Cancer Imaging 2015 15(Suppl 1):P26 -
Effects of body composition as measured by CT on clinical outcomes in patients with oesophageal cancer
Citation: Cancer Imaging 2015 15(Suppl 1):P25 -
Imaging spectrum of lung adenocarcinoma with histopathological correlation
Citation: Cancer Imaging 2015 15(Suppl 1):P24 -
Lung and pleura
Citation: Cancer Imaging 2015 15(Suppl 1):O23 -
4th year medical student elective in multidisciplinary thoracic oncology
Citation: Cancer Imaging 2015 15(Suppl 1):P23 -
Benign lesions that mimic cancer: Ovarian
Citation: Cancer Imaging 2015 15(Suppl 1):O22 -
Imaging the Ancients
Citation: Cancer Imaging 2015 15(Suppl 1):O21 -
Chemotherapy induced cardiomyopathy: an overview, imaging features, and future prospective
Citation: Cancer Imaging 2015 15(Suppl 1):P21 -
Lung cancer staging
Citation: Cancer Imaging 2015 15(Suppl 1):O20 -
A pictorial series of interesting and unusual cases of breast malignancy encountered at triple assessment
Citation: Cancer Imaging 2015 15(Suppl 1):P19 -
Relating neurological symptoms to cerebral metastases at the time of initial staging scan
Citation: Cancer Imaging 2015 15(Suppl 1):P17 -
Gadobenate dimeglumine (MultiHance) or gadoterat emeglumine (Dotarem) for brain tumour imaging? An intra-individual comparison
Citation: Cancer Imaging 2015 15(Suppl 1):P15 -
Patient experience of whole body diffusion weighted magnetic resonance imaging (WB-MRI) for staging myeloma
Citation: Cancer Imaging 2015 15(Suppl 1):P13 -
CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
Citation: Cancer Imaging 2015 15(Suppl 1):S12 -
Value of PET-CT in plasma cell dyscrasias: a literature and pictorial review
Citation: Cancer Imaging 2015 15(Suppl 1):P11 -
Quantification of tumour heterogeneity and glucose metabolism on pre-chemoradiation PET/CT predicts survival in anal cancer
Citation: Cancer Imaging 2015 15(Suppl 1):S11 -
Comparison of standard staging protocol and WB-MRI for initial staging of rectal cancer
Citation: Cancer Imaging 2015 15(Suppl 1):S9 -
First case report of usefulness of 18F-FDG PET/CT in diagnosing typhlitis (an oncological emergency)
Citation: Cancer Imaging 2015 15(Suppl 1):P8 -
Value of pretreatment MRI determined parameters for predicting outcome after radio-frequency ablation of hepatocellular carcinoma
Citation: Cancer Imaging 2015 15(Suppl 1):S7 -
Comparison of functional imaging in multiple myeloma patients: Indication for hybrid-imaging with PET/MRI?
Citation: Cancer Imaging 2015 15(Suppl 1):S6 -
Factors in the success of the subcutaneous central venous port catheter in 626 colorectal carcinoma patients: long-term follow-up results according to the treatment groups
Citation: Cancer Imaging 2015 15(Suppl 1):P6 -
Imaging of IPMN of the pancreas: evaluation of malignant potential and resectability
Citation: Cancer Imaging 2015 15(Suppl 1):O6 -
Pre-treatment ADC histogram-analysis at whole body diffusion-weighted MRI predicts disease free survival in ovarian cancer
Citation: Cancer Imaging 2015 15(Suppl 1):S5 -
Hepatocellularcarcinoma: current imaging techniques
Citation: Cancer Imaging 2015 15(Suppl 1):P4 -
Spots and dots in the bones
Citation: Cancer Imaging 2015 15(Suppl 1):O4 -
Contrast enhancement for early cancer imaging by Gd-nanoparticles and active feedback MRI
Citation: Cancer Imaging 2015 15(Suppl 1):P2 -
Advanced abdominal imaging with dual energy CT is feasible without increasing radiation dose
Citation: Cancer Imaging 2015 15(Suppl 1):P1 -
Background/CASPAR study
Citation: Cancer Imaging 2015 15(Suppl 1):O1 -
Multiparametric magnetic resonance tomography and MRI/TRUS-fusion-biopsy for index lesion detection: correlation with radical prostatectomy specimen
Citation: Cancer Imaging 2015 15(Suppl 1):S1
Official journal of
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 3.5
5-year Journal Impact Factor: 4.3
Source Normalized Impact per Paper (SNIP): 1.416
SCImago Journal Rank (SJR): 1.227Speed 2023
Submission to first editorial decision (median days): 13
Submission to acceptance (median days): 123Usage 2023
Downloads: 1,045,188
Altmetric mentions: 349